chr6-33196472-C-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_021976.5(RXRB):c.955G>A(p.Val319Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000146 in 1,613,080 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_021976.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RXRB | NM_021976.5 | c.955G>A | p.Val319Ile | missense_variant | 5/10 | ENST00000374680.4 | NP_068811.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RXRB | ENST00000374680.4 | c.955G>A | p.Val319Ile | missense_variant | 5/10 | 1 | NM_021976.5 | ENSP00000363812 | P4 | |
RXRB | ENST00000374685.8 | c.955G>A | p.Val319Ile | missense_variant | 5/10 | 1 | ENSP00000363817 | A1 | ||
RXRB | ENST00000481441.1 | n.643G>A | non_coding_transcript_exon_variant | 3/3 | 2 | |||||
RXRB | ENST00000483281.5 | c.*467G>A | 3_prime_UTR_variant, NMD_transcript_variant | 4/9 | 5 | ENSP00000431369 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152220Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000239 AC: 59AN: 246464Hom.: 0 AF XY: 0.000231 AC XY: 31AN XY: 134376
GnomAD4 exome AF: 0.000141 AC: 206AN: 1460742Hom.: 0 Cov.: 32 AF XY: 0.000144 AC XY: 105AN XY: 726684
GnomAD4 genome AF: 0.000197 AC: 30AN: 152338Hom.: 0 Cov.: 32 AF XY: 0.000242 AC XY: 18AN XY: 74484
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 21, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at